1979. Time to Viral Suppression Does Not Impact SVR in Patients Treated With Glecaprevir/Pibrentasvir for 8 Weeks

Por Sarrazin, Christoph, Tran, Tram, Dylla, Douglas, Feld, Jordan J, Arora, Sanjeev, Victor, David, Hu, Yiran B, Wang, Stanley, Mensa, Federico, Wyles, David L
Publicado no Open Forum Infect Dis (2018)

Safety and efficacy of ombitasvir – 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens

Por Eron, Joseph J, Lalezari, Jay, Slim, Jihad, Gathe, Joseph, Ruane, Peter J, Wang, Chia, Elion, Richard, Blick, Gary, Khatri, Amit, Hu, Yiran B, Gibbons, Krystal, Fredrick, Linda, Co, Melannie, D'Amico, Ronald, Da Silva-Tillmann, Barbara, Trinh, Roger, Sulkowski, Mark S
Publicado no J Int AIDS Soc (2014)

Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection

Por Reau, Nancy, Kwo, Paul Y., Rhee, Susan, Brown, Robert S., Agarwal, Kosh, Angus, Peter, Gane, Edward, Kao, Jia‐Horng, Mantry, Parvez S., Mutimer, David, Reddy, K. Rajender, Tran, Tram T., Hu, Yiran B., Gulati, Abhishek, Krishnan, Preethi, Dumas, Emily O., Porcalla, Ariel, Shulman, Nancy S., Liu, Wei, Samanta, Suvajit, Trinh, Roger, Forns, Xavier
Publicado no Hepatology (2018)

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype...

Por Rockstroh, Jürgen K, Orkin, Chloe, Viani, Rolando M, Wyles, David, Luetkemeyer, Anne F, Lazzarin, Adriano, Soto-Malave, Ruth, Nelson, Mark R, Bhagani, Sanjay R, Klinker, Hartwig H F, Rizzardini, Giuliano, Girard, Pierre-Marie, Tural, Cristina, Shulman, Nancy S, Mobashery, Niloufar, Hu, Yiran B, Fredrick, Linda M, Pilot-Matias, Tami, Trinh, Roger, Gane, Edward
Publicado no Open Forum Infect Dis (2017)